Cited by 62Gestational Diabetes Research and ManagementGrowth Hormone and Insulin-like Growth FactorsPregnancy and preeclampsia studies

Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes

Open access
Hivert, Marie-France, White, Frédérique, Allard, Catherine, James, Kaitlyn, Majid, Sana, Aguet, François, Ardlie, Kristin G., Florez, Jose C. +5 more·2024·Nature Medicine

Published version of a preprint

Abstract

Reduced insulin sensitivity (insulin resistance) is a hallmark of normal physiology in late pregnancy and also underlies gestational diabetes mellitus (GDM). We conducted transcriptomic profiling of 434 human placentas and identified a positive association between insulin-like growth factor binding protein 1 gene ( IGFBP1 ) expression in the placenta and insulin sensitivity at ~26 weeks gestation. Circulating IGFBP1 protein levels rose over the course of pregnancy and declined postpartum, which, together with high gene expression levels in our placenta samples, suggests a placental or decidual source. Higher circulating IGFBP1 levels were associated with greater insulin sensitivity (lesser insulin resistance) at ~26 weeks gestation in the same cohort and in two additional pregnancy cohorts. In addition, low circulating IGFBP1 levels in early pregnancy predicted subsequent GDM diagnosis in two cohorts of pregnant women. These results implicate IGFBP1 in the glycemic physiology of pregnancy and suggest a role for placental IGFBP1 deficiency in GDM pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-024-02936-5

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 70 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Hivert, M.-F., White, F., Allard, C., James, K., Majid, S., Aguet, F., Ardlie, K. G., Florez, J. C., Edlow, A. G., Bouchard, L., Jacques, P.-É., Karumanchi, S. A., & Powe, C. E.
Affiliations
  • Harvard University (US)
  • Université de Sherbrooke (CA)
  • Centre de recherche du CHUS (CA)
  • Broad Institute (US)
  • Cedars-Sinai Medical Center (US)
Corresponding author
Hivert, Marie-France
Venue
Nature Medicine
Published
2024-04-16
Volume
30
Issue
6
Pages
1689-1695
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4394832188
Cited by
62
References
70
Citations by year
2026: 26 · 2025: 27 · 2024: 9
FWCI
34.34
Type
journal article
Language
en
Open access
Locations
  • Nature Medicine (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by)
Funders
  • U.S. Department of Health and Human Services (K23DK113218, R01HD094150, NHLBI K24 HL157960)
  • American Diabetes Association (1-15-ACE-26)
  • Harvard Catalyst (UL1TR000170, UL1-TR-001102)
  • Diabète Québec (20697, MOP 115071)
  • Government of Canada (#MOP 115071, #PJT-152989)
  • National Institutes of Health (UL1TR000170, UL1TR001102)
  • Canadian Institutes of Health Research (PJT152989, MOP – 115071, 115071, 152989)
  • Fonds de Recherche du Québec - Santé (#20697)
  • National Heart, Lung, and Blood Institute (K24HL157960)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K23DK113218)
  • National Center for Advancing Translational Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD094150)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
IGFBP-1, placenta, insulin resistance, gestational diabetes mellitus, early pregnancy, insulin sensitivity, placental transcriptome, GDM risk prediction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review